Login / Signup

Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4.

Mao LuoChunrong XuYulin LuoGang WangJianbo WuQin Wan
Published in: Acta diabetologica (2019)
These findings suggest that circulating miR-103a and miR-103b may serve as novel biomarkers for diagnosis of DM2, providing novel insight into the mechanisms underlying pre-DM.
Keyphrases
  • cell proliferation
  • type diabetes
  • long non coding rna
  • glycemic control
  • long noncoding rna
  • cardiovascular disease
  • cancer therapy
  • insulin resistance